Skip to main content
. 2016 Jun 9;1:16006. doi: 10.1038/npjregenmed.2016.6

Figure 3.

Figure 3

Potential therapeutic targets to improve dystrophin-deficient satellite cell function. Schematic micrograph of a satellite cell membrane. Various signalling pathways are dysregulated in dystrophin-deficient satellite cells. Different therapeutic compounds such as Wnt7a, Notch activators, Jak2/Stat3 inhibitors and p38MAPK inhibitors were shown to rescue satellite cell function and are potential therapeutic targets.